메뉴 건너뛰기




Volumn 18, Issue 3, 2011, Pages 415-423

Predictors of early-stage left ventricular dysfunction in type 2 diabetes: Results of DYDA study

Author keywords

Early stage left ventricular dysfunction; Predictive factors; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; ALDOSTERONE ANTAGONIST; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; LIVER ENZYME; METFORMIN; REPAGLINIDE; SULFONYLUREA; THIAZIDE DIURETIC AGENT;

EID: 79959187619     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/1741826710389402     Document Type: Article
Times cited : (33)

References (26)
  • 1
    • 0016251063 scopus 로고
    • Role of diabetes in congestive heart failure: The Framingham Study
    • Kannel WB, Hjortland M and Castelli WP. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol 1974; 34: 29-34.
    • (1974) Am J Cardiol , vol.34 , pp. 29-34
    • Kannel, W.B.1    Hjortland, M.2    Castelli, W.P.3
  • 3
    • 0037783946 scopus 로고    scopus 로고
    • The impact of diabetes-related complications on healthcare costs: Results from the UK Prospective Diabetes Study (UKPDS Study No. 65)
    • Clarke P, Gray A, Legood R, Briggs A and Holman R. The impact of diabetes-related complications on healthcare costs: results from the UK Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med 2003; 20: 442-450.
    • (2003) Diabet Med , vol.20 , pp. 442-450
    • Clarke, P.1    Gray, A.2    Legood, R.3    Briggs, A.4    Holman, R.5
  • 4
    • 0041356972 scopus 로고    scopus 로고
    • Natural history of asymptomatic left ventricular systolic dysfunction in the community
    • DOI 10.1161/01.CIR.0000085166.44904.79
    • Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC and Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003; 108(8): 977-982. (Pubitemid 37048228)
    • (2003) Circulation , vol.108 , Issue.8 , pp. 977-982
    • Wang, T.J.1    Evans, J.C.2    Benjamin, E.J.3    Levy, D.4    LeRoy, E.C.5    Vasan, R.S.6
  • 5
    • 1642502319 scopus 로고    scopus 로고
    • National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • National Kidney Foundation
    • Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al.; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
    • (2003) Ann Intern Med , vol.139 , pp. 137-147
    • Levey, A.S.1    Coresh, J.2    Balk, E.3    Kausz, A.T.4    Levin, A.5    Steffes, M.W.6
  • 6
    • 84870967607 scopus 로고    scopus 로고
    • Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: The DYDA study
    • under review
    • Cioffi G, Giorda CB, Chinali M, Di Lenarda A, Faggiano P, Lucci D, et al. Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study. Eur J Cardiovasc Prev Rehabil 2010, under review.
    • (2010) Eur J Cardiovasc Prev Rehabil
    • Cioffi, G.1    Giorda, C.B.2    Chinali, M.3    Di Lenarda, A.4    Faggiano, P.5    Lucci, D.6
  • 8
    • 0035845307 scopus 로고    scopus 로고
    • Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study
    • DOI 10.1016/S0140-6736(01)05620-3
    • Davies M, Hobbs F, Davis R, Kenkre J, Roalfe AK, Hare R, et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001; 358: 439-444. (Pubitemid 32769849)
    • (2001) Lancet , vol.358 , Issue.9280 , pp. 439-444
    • Davies, M.K.1    Hobbs, F.D.R.2    Davis, R.C.3    Kenkre, J.E.4    Roalfe, A.K.5    Hare, R.6    Wosornu, D.7    Lancashire, R.J.8
  • 10
    • 62649111631 scopus 로고    scopus 로고
    • Is the aging heart similar to the diabetic heart? Evaluation of LV function of the aging heart with tissue doppler imaging
    • Cacciapuoti F, Marfella R, Paolisso G and Cacciapuoti F. Is the aging heart similar to the diabetic heart? Evaluation of LV function of the aging heart with tissue doppler imaging. Aging Clin Exp Res 2009; 21: 22-26.
    • (2009) Aging Clin Exp Res , vol.21 , pp. 22-26
    • Cacciapuoti, F.1    Marfella, R.2    Paolisso, G.3    Cacciapuoti, F.4
  • 11
    • 66549122728 scopus 로고    scopus 로고
    • Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus
    • Goode KM, John J, Rigby AS, Kilpatrick ES, Atkin SL, Bragadeesh T, et al. Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus. Heart 2009; 95: 917-923.
    • (2009) Heart , vol.95 , pp. 917-923
    • Goode, K.M.1    John, J.2    Rigby, A.S.3    Kilpatrick, E.S.4    Atkin, S.L.5    Bragadeesh, T.6
  • 12
    • 0026700511 scopus 로고
    • Effects of metabolic control on ventricular function in type 2 diabetic patients
    • Hirai J, Ueda K, Takegoshi T and Mabuchi H. Effects of metabolic control on ventricular function in type 2 diabetic patients. Intern Med 1992; 31: 725-730.
    • (1992) Intern Med , vol.31 , pp. 725-730
    • Hirai, J.1    Ueda, K.2    Takegoshi, T.3    Mabuchi, H.4
  • 13
    • 49449083742 scopus 로고    scopus 로고
    • The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
    • CHARM Program Investigators
    • Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, et al.; CHARM Program Investigators. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med 2008; 168: 1699-1704.
    • (2008) Arch Intern Med , vol.168 , pp. 1699-1704
    • Gerstein, H.C.1    Swedberg, K.2    Carlsson, J.3    McMurray, J.J.4    Michelson, E.L.5    Olofsson, B.6
  • 15
    • 34247880463 scopus 로고    scopus 로고
    • Incidence and risk factors for stroke in type 2 diabetic patients: The DAI study
    • DAI Study Group
    • Giorda CB, Avogaro A, Maggini M, Lombardo F, Mannucci E, Turco S, et al.; DAI Study Group. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 2007; 38: 1154-1160.
    • (2007) Stroke , vol.38 , pp. 1154-1160
    • Giorda, C.B.1    Avogaro, A.2    Maggini, M.3    Lombardo, F.4    Mannucci, E.5    Turco, S.6
  • 16
    • 17444386290 scopus 로고    scopus 로고
    • Determinants of subclinical diabetic heart disease
    • DOI 10.1007/s00125-004-1632-z
    • Fang ZY, Schull-Meade R, Downey M, Prins J and Marwick TH. Determinants of subclinical diabetic heart disease. Diabetologia 2005; 48: 394-402. (Pubitemid 40543314)
    • (2005) Diabetologia , vol.48 , Issue.2 , pp. 394-402
    • Fang, Z.Y.1    Schull-Meade, R.2    Downey, M.3    Prins, J.4    Marwick, T.H.5
  • 17
    • 34247253225 scopus 로고    scopus 로고
    • The safety of metformin in heart failure
    • DOI 10.1345/aph.1H523
    • Roberts F and Ryan GJ. The safety of metformin in heart failure. Ann Pharmacother 2007; 41: 642-646. (Pubitemid 46625487)
    • (2007) Annals of Pharmacotherapy , vol.41 , Issue.4 , pp. 642-646
    • Roberts, F.1    Ryan, G.J.2
  • 18
    • 34548603259 scopus 로고    scopus 로고
    • Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: Systematic review
    • Eurich DT, McAlister FA, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J, et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ 2007; 335: 497.
    • (2007) BMJ , vol.335 , pp. 497
    • Eurich, D.T.1    McAlister, F.A.2    Blackburn, D.F.3    Majumdar, S.R.4    Tsuyuki, R.T.5    Varney, J.6
  • 19
    • 0032860998 scopus 로고    scopus 로고
    • 2+ transients in adult rat ventricular myocytes
    • DOI 10.2337/diabetes.48.10.2059
    • Ren J, Dominguez LJ, Sowers JR and Davidoff AJ. Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes. Diabetes 1999; 48: 2059-2065. (Pubitemid 29458372)
    • (1999) Diabetes , vol.48 , Issue.10 , pp. 2059-2065
    • Ren, J.1    Dominguez, L.J.2    Sowers, J.R.3    Davidoff, A.J.4
  • 20
    • 17844393082 scopus 로고    scopus 로고
    • Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding
    • Mamdani M, Sykora K, Li P, Notmand TS-L, Steiner LD, Austin CP, et al. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005; 330: 960-962.
    • (2005) BMJ , vol.330 , pp. 960-962
    • Mamdani, M.1    Sykora, K.2    Li, P.3    Notmand, T.S.-L.4    Steiner, L.D.5    Austin, C.P.6
  • 22
    • 0042835370 scopus 로고    scopus 로고
    • Diuretic versus alpha-blocker as first-step antihypertensive therapy: Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
    • Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2003; 42: 239-246.
    • (2003) Hypertension , vol.42 , pp. 239-246
  • 23
    • 0037453063 scopus 로고    scopus 로고
    • Glitazones and heart failure: Critical appraisal for the clinician
    • DOI 10.1161/01.CIR.0000054675.30348.9A
    • Wang CH, Weisel RD, Liu PP, Fedak PW and Verma S. Glitazones and heart failure: critical appraisal for the clinician. Circulation 2003; 107: 1350-1354. (Pubitemid 36350730)
    • (2003) Circulation , vol.107 , Issue.10 , pp. 1350-1354
    • Wang, C.-H.1    Weisel, R.D.2    Liu, P.P.3    Fedak, P.W.M.4    Verma, S.5
  • 24
    • 0035797865 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes
    • Yamamoto K, Ohki R, Lee RT, Ikeda U and Shimada K. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 2001; 104: 1670-1675. (Pubitemid 32947532)
    • (2001) Circulation , vol.104 , Issue.14 , pp. 1670-1675
    • Yamamoto, K.1    Ohki, R.2    Lee, R.T.3    Ikeda, U.4    Shimada, K.5
  • 25
    • 42649097971 scopus 로고    scopus 로고
    • Relation among left ventricular mass, insulin resistance, and hemodynamic parameters in type 2 diabetes
    • DOI 10.1291/hypres.31.425
    • Ozasa N, Furukawa Y, Tadamura E, Kita T and Kimura T. Relation among left ventricular mass, insulin resistance, and hemodynamic parameters in type 2 diabetes. Hypertens Res 2008; 31: 425-432. (Pubitemid 351597495)
    • (2008) Hypertension Research , vol.31 , Issue.3 , pp. 425-432
    • Ozasa, N.1    Furukawa, Y.2    Morimoto, T.3    Tadamura, E.4    Kita, T.5    Kimura, T.6
  • 26
    • 43549099569 scopus 로고    scopus 로고
    • Biomarkers in heart failure
    • Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358: 2148-2159.
    • (2008) N Engl J Med , vol.358 , pp. 2148-2159
    • Braunwald, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.